It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The human gut is inhabited by a complex and metabolically active microbial ecosystem. While many studies focused on the effect of individual microbial taxa on human health, their overall metabolic potential has been under-explored. Using whole-metagenome shotgun sequencing data in 1,004 twins, we first observed that unrelated subjects share, on average, almost double the number of metabolic pathways (82%) than species (43%). Then, using 673 blood and 713 faecal metabolites, we found metabolic pathways to be associated with 34% of blood and 95% of faecal metabolites, with over 18,000 significant associations, while species showed less than 3,000 associations. Finally, we estimated that the microbiome was involved in a dialogue between 71% of faecal, and 15% of blood, metabolites. This study underlines the importance of studying the microbial metabolic potential rather than focusing purely on taxonomy to find therapeutic and diagnostic targets, and provides a unique resource describing the interplay between the microbiome and the systemic and faecal metabolic environments.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Le Roy, Caroline I 1 ; Rosa, Fabio 1 ; Rossi, Niccolò 2 ; Martin, Tiphaine C 3 ; Mohney, Robert P 4
; Li, Weizhong 5
; de Rinaldis, Emanuele 6 ; Bell, Jordana T 1
; Venter, J Craig 5 ; Nelson, Karen E 5 ; Spector, Tim D 1 ; Falchi, Mario 1 1 Department of Twin Research & Genetic Epidemiology, King’s College London, London, UK
2 Department of Twin Research & Genetic Epidemiology, King’s College London, London, UK; BioISI—Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal
3 Department of Twin Research & Genetic Epidemiology, King’s College London, London, UK; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
4 Metabolon, Inc., Morrisville, NC, USA
5 Human Longevity, Inc, San Diego, CA, USA; J. Craig Venter Institute, La Jolla, CA, USA
6 Immunology & Inflammation, Cluster of Precision Immunology, Sanofi, Cambridge, MA, USA




